Effect of ethinylestradiol dose and progestagen in combined oral contraceptives on plasma sex hormone-binding globulin levels in premenopausal women

被引:14
作者
Stegeman, B. H. [1 ,2 ]
Raps, M. [3 ]
Helmerhorst, F. M. [3 ,4 ]
Vos, H. L. [1 ,2 ]
van Vliet, H. A. A. M. [4 ,5 ]
Rosendaal, F. R. [1 ,2 ,3 ]
Vlieg, A. van Hylckama [2 ,3 ]
机构
[1] Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands
[4] Leiden Univ, Med Ctr, Dept Gynecol & Reprod Med, Leiden, Netherlands
[5] Catharina Hosp, Dept Gynecol, Eindhoven, Netherlands
关键词
VENOUS THROMBOEMBOLISM; RISK;
D O I
10.1111/jth.12054
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:203 / 205
页数:3
相关论文
共 7 条
  • [1] Malignancies, prothrombotic mutations, and the risk of venous thrombosis
    Blom, JW
    Doggen, CJM
    Osanto, S
    Rosendaal, FR
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (06): : 715 - 722
  • [2] A METABOLIC ASSESSMENT OF DIFFERENT ORAL-CONTRACEPTIVES
    FOTHERBY, K
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1983, 3 : S77 - S82
  • [3] Oral contraceptives and venous thromboembolism:: a five-year national case-control study
    Lidegaard, O
    Edström, B
    Kreiner, S
    [J]. CONTRACEPTION, 2002, 65 (03) : 187 - 196
  • [4] Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills? A discussion based on recent recommendations from the European agency for evaluation of medicinal products regarding third generation oral contraceptive pills
    Odlind, V
    Milsom, I
    Persson, I
    Victor, A
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2002, 81 (06) : 482 - 490
  • [5] STADEL BV, 1980, FERTIL STERIL, V33, P257
  • [6] Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens
    van Vliet, HAAM
    Frolich, M
    Christella, M
    Thomassen, LGD
    Doggen, CJM
    Rosendaal, FR
    Rosing, J
    Helmerhorst, FM
    [J]. HUMAN REPRODUCTION, 2005, 20 (02) : 563 - 568
  • [7] The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study
    Vlieg, A. van Hylckama
    Helmerhorst, F. M.
    Vandenbroucke, J. P.
    Doggen, C. J. M.
    Rosendaal, F. R.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2009, 339 : 561